Phase II Panitumumab-IRDye800 in Head & Neck Cancer

Clinical trial NCT04511078 · RECRUITING

Trial details

NCT number: NCT04511078
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2021-04-02
Primary completion: 2030-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.